NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

經導管主動脈瓣置換術 (TAVR) / 移植術 (TAVI)的全球市場

Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market

出版商 Life Science Intelligence 商品編碼 1011650
出版日期 內容資訊 英文 11 Pages
商品交期: 最快1-2個工作天內
價格
經導管主動脈瓣置換術 (TAVR) / 移植術 (TAVI)的全球市場 Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market
出版日期: 2021年06月01日內容資訊: 英文 11 Pages
簡介

本報告提供全球經導管主動脈瓣置換術 (TAVR)/移植術 (TAVI) 市場相關調查分析,最新的市場資料。包含以下資訊。

  • 銷售數量和價格預測 (2020年∼2025年)
  • 主要企業分析
  • 全球市場佔有率分析

包含2020年∼2025年的最新預測,關於對心臟瓣膜置換術的COVID-19的影響報告。還有COVID-19,也帶給Abbott、Boston Scientific、Medtronic、Edwards Lifesciences等市場主要競爭企業影響。提供對經導管主動脈心臟瓣膜市場趨勢、促進因素、阻礙因素的考察,出示潛在的機會。

目錄
Product Code: #LSI-06012021-Transcatheter

This report from Life Science Intelligence provides the latest market data for the Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market. Information covered by this report includes:

  • unit volumes & pricing forecast from 2020-2025
  • analyses of the leading companies, and
  • global market share analysis.

This report covers the impact of COVID-19 on heart valve replacement procedures, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Medtronic, Edwards Lifesciences, and others. The report provides insights into trends, drivers, and limiters of the transcatheter aortic heart valves market, as well as highlights potential opportunities.